| 1 |
Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke)
Michael T. Froehler et al. · Circulation
Open access |
25 Sep 2017 |
425 |
| 2 |
Posttraumatic Stress and Depressive Reactions Among Children and Adolescents After the 1999 Earthquake in Ano Liosia, Greece
Alexandra C. Roussos, Armen K. Goenjian, Alan M. Steinberg et al. · American Journal of Psychiatry
|
Mar 2005 |
397 |
| 3 |
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
Joseph J. Jankovic, Ira J. Goodman, Beth Safirstein et al. · JAMA Neurology
Open access |
18 Jun 2018 |
303 |
| 4 |
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Danna L. Jennings et al. · Science Translational Medicine
|
8 Jun 2022 |
266 |
| 5 |
Reconsidering Models of Influence: The Relationship between Consumer Social Networks and Word-of-Mouth Effectiveness
Ted Smith, James R. Coyle, Elizabeth Lightfoot et al. · Journal of Advertising Research
|
Dec 2007 |
250 |
| 6 |
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Earle Bain, Laura Shafner, David P. Walling et al. · JMIR mhealth and uhealth
Open access |
21 Feb 2017 |
168 |
| 7 |
Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
Michael F. Green, Nina R. Schooler, Robert S Kern et al. · American Journal of Psychiatry
|
Feb 2011 |
159 |
| 8 |
Longitudinal study of PTSD, depression, and quality of life among adolescents after the Parnitha earthquake
Armen K. Goenjian, Alexandra C. Roussos, Alan M. Steinberg et al. · Journal of Affective Disorders
|
19 Jun 2011 |
154 |
| 9 |
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela P. Perry et al. · The British Journal of Psychiatry
Open access |
13 Jun 2014 |
153 |
| 10 |
Thrombectomy for Stroke With Large Infarct on Noncontrast CT
Rhonda R. White et al. · JAMA
Open access323 authors |
23 Sep 2024 |
144 |
| 11 |
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study
W. Wolfgang Fleischhacker, Jana Podhorná, Martina Gröschl et al. · The Lancet Psychiatry
|
21 Feb 2021 |
138 |
| 12 |
Impact of Balloon Guide Catheter Use on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry
Osama O. Zaidat et al. · Stroke
|
19 Feb 2019 |
130 |
| 13 |
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
David H. Adams, Bruce J. Kinon, Simin Baygani et al. · BMC Psychiatry
Open access |
22 May 2013 |
116 |
| 14 |
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
John Harrison Krystal, John Michael Kane, Christoph Ulrich Correll et al. · The Lancet
|
Dec 2022 |
113 |
| 15 |
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
David P. Walling, Stephen R. Marder, John Michael Kane et al. · Schizophrenia Bulletin
Open access |
12 Jun 2015 |
97 |
| 16 |
Impact of Stent Retriever Size on Clinical and Angiographic Outcomes in the STRATIS Stroke Thrombectomy Registry
Osama O. Zaidat, Diogo C Haussen, Ameer E Hassan et al. · Stroke
|
10 Jan 2019 |
89 |
| 17 |
Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia
Theresa A. Zesiewicz, Frederic Heerinckx, Robert De Jager et al. · Movement Disorders
|
6 Apr 2018 |
89 |
| 18 |
Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder
Dong‐Jing Fu, Ibrahim Turkoz, Richard Bruce Simonson et al. · The Journal of Clinical Psychiatry
Open access |
5 Dec 2014 |
87 |
| 19 |
Depression and PTSD symptoms among bereaved adolescents 6½ years after the 1988 spitak earthquake
Armen K. Goenjian, David P. Walling, Alan M. Steinberg et al. · Journal of Affective Disorders
|
11 Jun 2008 |
81 |
| 20 |
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Tim Peters-Strickland, Linda K. Pestreich, Ainslie Hatch et al. · Neuropsychiatric Disease and Treatment
Open access |
Oct 2016 |
73 |
| 21 |
Risk Factors Associated With Psychiatric Readmission
Kim Lorine, Haig A. Goenjian, Soeun Kim et al. · The Journal of Nervous and Mental Disease
|
14 May 2015 |
70 |
| 22 |
Paliperidone Extended-Release in Schizoaffective Disorder
Carla M. Canuso, Nina R. Schooler, Jennifer Carothers et al. · Journal of Clinical Psychopharmacology
|
2 Sep 2010 |
69 |
| 23 |
A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
Dean M. Najarian, Panna Sanga, Steven Wang et al. · The International Journal of Neuropsychopharmacology
Open access |
10 Nov 2021 |
64 |
| 24 |
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
Michael H Davidson, Jay B. Saoud, Corinne Staner et al. · Schizophrenia Bulletin
Open access |
27 Jan 2022 |
63 |
| 25 |
Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms
Armen K. Goenjian, Julia N. Bailey, David P. Walling et al. · Journal of Affective Disorders
|
5 Apr 2012 |
60 |
| 26 |
Subarachnoid Hemorrhage in Mechanical Thrombectomy for Acute Ischemic Stroke: Analysis of the STRATIS Registry, Systematic Review, and Meta-Analysis
Hubert Lee, Ayman M. Qureshi, Nils H. Mueller‐Kronast et al. · Frontiers in Neurology
ReviewOpen access |
25 May 2021 |
56 |
| 27 |
First Pass Effect With Neurothrombectomy for Acute Ischemic Stroke: Analysis of the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke Registry
Ashutosh Prabhakar Jadhav, Shashvat M. Desai, Osama O. Zaidat et al. · Stroke
Open access |
17 Nov 2021 |
53 |
| 28 |
Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry
Osama O. Zaidat, David S. Liebeskind, Ashutosh Prabhakar Jadhav et al. · Stroke
Open access |
3 Jun 2021 |
52 |
| 29 |
New Class of Radially Adjustable Stentrievers for Acute Ischemic Stroke
Rishi G. Gupta et al. · Stroke
Open access |
19 Mar 2021 |
52 |
| 30 |
PTSD and dopaminergic genes, DRD2 and DAT, in multigenerational families exposed to the Spitak earthquake
Julia N. Bailey, Armen K. Goenjian, Ernest Pascal Noble et al. · Psychiatry Research
|
8 Jun 2010 |
47 |
| 31 |
25-year follow-up of treated and not-treated adolescents after the Spitak earthquake: course and predictors of PTSD and depression
Armen K. Goenjian, Alan M. Steinberg, David P. Walling et al. · Psychological Medicine
Open access |
14 Jan 2020 |
43 |
| 32 |
Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
David Brown, Kazuyuki Nakagome, Joachim Cordes et al. · Schizophrenia Bulletin
Open access |
24 Apr 2018 |
42 |
| 33 |
Cognitive Functioning Predicts Outpatient Service Utilization in Schizophrenia
Susan R. McGurk, Kim T. Mueser, David P. Walling et al. · Mental Health Services Research
|
3 Aug 2004 |
42 |
| 34 |
A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia
Laura Redden, Beatrice Rendenbach‐Mueller, Walid Abi‐Saab et al. · Journal of Clinical Psychopharmacology
|
23 Feb 2011 |
39 |
| 35 |
Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia
David P. Walling, Anindita Banerjee, Vikas Kumar Dawra et al. · Journal of Clinical Psychopharmacology
Open access |
Nov 2019 |
37 |
| 36 |
Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia
Dawn I. Velligan, Ronald Brenner, Franco Sicuro et al. · Schizophrenia Research
|
16 Nov 2011 |
36 |
| 37 |
Factor Structure and Psychometric Properties of the Posttraumatic Stress Disorder (PTSD) Checklist and DSM-5 PTSD Symptom Set in a Long-Term Postearthquake Cohort in Armenia
Anahit Demirchyan, Armen K. Goenjian, Vahe Khachadourian · Assessment
|
27 Oct 2014 |
36 |
| 38 |
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
Nicholas A. DeMartinis, Rene N. Lopez, Eve H. Pickering et al. · Journal of Clinical Psychopharmacology
|
12 Jun 2019 |
35 |
| 39 |
Physiologic and Nanoscale Distinctions Define Glutamatergic Synapses in Tonic vs Phasic Neurons
Kaikai He, Yifu Han, Xiling Li et al. · Journal of Neuroscience
Open access |
23 May 2023 |
34 |
| 40 |
Heritabilities of symptoms of posttraumatic stress disorder, anxiety, and depression in earthquake exposed Armenian families
Armen K. Goenjian, Ernest Pascal Noble, David P. Walling et al. · Psychiatric Genetics
|
11 Nov 2008 |
33 |
| 41 |
Middle Cerebral Artery M2 Thrombectomy in the STRATIS Registry
Mouhammad A. Jumaa, Alicia C. Castonguay, Hisham Salahuddin et al. · Stroke
|
27 Jul 2021 |
32 |
| 42 |
Impact of EMS bypass to endovascular capable hospitals: geospatial modeling analysis of the US STRATIS registry
Nils H. Mueller‐Kronast, Michael T. Froehler, Reza Jahan et al. · Journal of NeuroInterventional Surgery
Open access |
8 May 2020 |
27 |
| 43 |
Promoting physical activity for mental health: an updated evidence review and practical guide
Grace McKeon, Jackie Curtis, Simon Rosenbaum · Current Opinion in Psychiatry
|
8 Jun 2022 |
26 |
| 44 |
Association of COMT and TPH-2 genes with DSM-5 based PTSD symptoms
Armen K. Goenjian, Ernest Pascal Noble, Alan M. Steinberg et al. · Journal of Affective Disorders
|
22 Oct 2014 |
25 |
| 45 |
Intra-Arterial Thrombolysis after Unsuccessful Mechanical Thrombectomy in the STRATIS Registry
Syed Zaidi, Alicia C. Castonguay, Osama O. Zaidat et al. · American Journal of Neuroradiology
Open access |
28 Jan 2021 |
23 |
| 46 |
Efficacy and Safety of HP-3070, an Asenapine Transdermal System, in Patients With Schizophrenia
Leslie Citrome, David P. Walling, Courtney M. Zeni et al. · The Journal of Clinical Psychiatry
Open access |
14 Dec 2020 |
23 |
| 47 |
Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care
Peter J. Weiden, Amy Claxton, Jelena L. Kunovac et al. · The Journal of Clinical Psychiatry
|
18 May 2020 |
20 |
| 48 |
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study
David P. Walling, Howard A Hassman, Lourdes Anta et al. · Drug Design Development and Therapy
Open access |
Oct 2021 |
19 |
| 49 |
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials
Steven D. Targum, Celine Houser, Joanne Northcutt et al. · Annals of General Psychiatry
Open access |
2013 |
18 |
| 50 |
Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
Peter J. Weiden, Yangchun Du, Lisa Von Moltke et al. · CNS Drugs
Open access |
3 Jul 2020 |
17 |